ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,813 | -62.2% | 9,890 | -68.4% | 0.00% | – |
| Q1 2023 | $68,254 | -86.8% | 31,309 | -26.9% | 0.00% | -100.0% |
| Q4 2022 | $515,257 | +175.5% | 42,831 | +48.7% | 0.00% | +200.0% |
| Q3 2022 | $187,000 | -23.0% | 28,795 | -45.8% | 0.00% | -50.0% |
| Q2 2022 | $243,000 | -50.1% | 53,128 | -5.7% | 0.00% | -50.0% |
| Q1 2022 | $487,000 | -47.4% | 56,348 | -13.0% | 0.00% | -42.9% |
| Q4 2021 | $925,000 | +320.5% | 64,799 | +294.9% | 0.01% | +133.3% |
| Q2 2021 | $220,000 | -4.3% | 16,407 | -69.8% | 0.00% | 0.0% |
| Q4 2020 | $230,000 | +16.8% | 54,291 | -28.0% | 0.00% | 0.0% |
| Q3 2020 | $197,000 | +245.6% | 75,395 | +365.7% | 0.00% | +200.0% |
| Q2 2020 | $57,000 | – | 16,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |